tert-Butyl (1-(4-bromophenyl)-3-oxocyclobutyl)carbamate

Catalog No. :
ACNKIX129
CAS No. :
1199556-68-7
Molecular Formula :
C15H18BrNO3
Molecular Weight :
340.22

IUPAC Name:tert-butyl (1-(4-bromophenyl)-3-oxocyclobutyl)carbamate

tert-Butyl (1-(4-bromophenyl)-3-oxocyclobutyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$121.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1-(4-bromophenyl)-3-oxocyclobutyl)carbamate
IUPAC Nametert-butyl (1-(4-bromophenyl)-3-oxocyclobutyl)carbamate
MDL No.MFCD17926307
Molecular FormulaC15H18BrNO3
Molecular Weight340.22
SMILESO=C(OC(C)(C)C)NC1(C2=CC=C(Br)C=C2)CC(C1)=O
InChI KeyYFSAGUKUTJZFQM-UHFFFAOYSA-N
Synonym[1-(4-BroMo-phenyl)-3-oxo-cyclobutyl]carbaMic acid tert-butyl ester;tert-butyl N-[1-(4-bromophenyl)-3-oxocyclobutyl]carbamate;tert-Butyl (1-(4-bromophenyl)-3-oxocyclobutyl)carbamate;1-Boc-amino-1-(4-bromophenyl)-3-oxocyclobutane;[1-(4-Bromophenyl)-3-oxo-cyclobutyl]carbamic acid tert-butyl ester - B11045;Carbamic acid, N-[1-(4-bromophenyl)-3-oxocyclobutyl]-, 1,1-dimethylethyl ester
CAS No.1199556-68-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P261-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACNKIX129 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNKIX129 route product structure diagram
    ACNKIX1291199556-68-7 In Stock
Inquiry

2. ACNKIX129 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNKIX129 route product structure diagram
    ACNKIX1291199556-68-7 In Stock
Inquiry

Comments (0)